Market Place
Sourcing Support
Laurus’s Generics Sitagliptin Receives Tentative Approval In US
12 Nov 2025 //
FDA
FDA Issues Form 483 to Laurus Lab
05 Nov 2025 //
FDA
Laurus’s Generics Macitentan Receives Approval in US
05 Nov 2025 //
FDA
Laurus Labs Posts Q2 FY26 Consolidated PAT Higher At Rs. 195 Cr
24 Oct 2025 //
INDPHARMAPOST
Laurus Labs Invests In Aarvik Series Seed 2 Round At Aarvik
08 Oct 2025 //
PHARMIWEB
Gilead Inks Biktarvy Settlements With 3 Generic Drug Makers
07 Oct 2025 //
FIERCE PHARMA
Laurus Labs Granted 531.77 Acres by Andhra Pradesh Govt.
28 Jul 2025 //
INDPHARMAPOST
Laurus Labs to Invest €5 Million in JV Krka Pharma
27 Jul 2025 //
INDPHARMAPOST
Laurus Labs Consolidated Q1 Fy2026 Pat at Rs. 163.02 Cr
26 Jul 2025 //
INDPHARMAPOST
Laurus`s Generics Flucytosine Receives Approval in US
23 Jul 2025 //
FDA
Laurus Labs Q4 FY25 PAT up 208% to Rs. 234 Cr
24 Apr 2025 //
INDPHARMAPOST
Indian pharma stocks decline after Trump again threatens tariffs
09 Apr 2025 //
REUTERS
Laurus Labs posts Q3 FY25 consolidated PAT higher at Rs. 92.30 Cr
28 Jan 2025 //
INDPHARMAPOST
Laurus Labs` arm gets Form 483 from FDA `adverse experience` probe
22 Jan 2025 //
CNBCTV
Laurus Labs invests in Laurus Bio
09 Dec 2024 //
INDPHARMAPOST
Laurus Labs posts Financial Results Q2 FY 2025
24 Oct 2024 //
PRESS RELEASE
Laurus Labs inaugurates new R&D facility at IKP Knowledge Park
19 Sep 2024 //
PRESS RELEASE
Laurus Labs opens new R&D facility in IKP Knowledge Park, Hyderabad
16 Sep 2024 //
ECONOMICTIMES
Laurus Labs API Facility Passes USFDA Audit With Zero Observations
14 Sep 2024 //
INDPHARMAPOST
Laurus Labs Q1 FY25: ?1,195 Cr Revenue, ?171 Cr EBITDA
25 Jul 2024 //
PRESS RELEASE
Willow Biosciences announces licensing partnership with Laurus Labs
30 May 2024 //
PRESS RELEASE
Willow Partners With Laurus For API Manufacturing And Development
30 May 2024 //
PR NEWSWIRE
FDA hits drugmaker Laurus Synthesis with a 2nd rebuke
28 May 2024 //
FIERCE PHARMA
Laurus Labs CEO confident of strong growth in CDMO business this year
25 May 2024 //
PRESS RELEASE
FDA Issues Untitled letter to Laurus Synthesis
22 May 2024 //
FDA
How Satyanarayana Chava converted Laurus Labs
17 May 2024 //
PRESS RELEASE
Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion
14 May 2024 //
REUTERS
Laurus` Generic Oseltamivir Phosphate Receives Approval in the U.S.
01 May 2024 //
FDA
Laurus Labs: CDMO business to accelerate from FY26
29 Apr 2024 //
MONEYCONTROL
Laurus Labs: CDMO services key to improved prospects, say analysts
26 Apr 2024 //
PRESS RELEASE
Laurus Labs posts Q4 FY24 consolidated PAT at Rs. 75.61 Cr
25 Apr 2024 //
INDINPHARMAPOST
Laurus Labs forms JV company
16 Apr 2024 //
INDINPHARMAPOST
Laurus` Generic Gabapentin Receives Approval in the U.S.
08 Apr 2024 //
FDA
Laurus Labs inks JV agreement with KRKA, Slovenia
26 Jan 2024 //
INDIAN PHARMA POST
Laurus Labs posts Q3 FY24 consolidated PAT at Rs. 23.14 Cr
25 Jan 2024 //
INDIAN PHARMA POST
FDA slams trio of Indian drugmakers with Form 483 filings
03 Jan 2024 //
FIERCE PHARMA
FDA Issues Form 483 to Laurus Synthesis Private Limited
28 Dec 2023 //
FDA
Laurus Labs acquires 87.59% stake in Laurus Bio Private
25 Nov 2023 //
INDIAN PHARMA POST
Laurus Labs Q2 FY24 consolidated PAT up QOQ at Rs. 36.95 Cr
21 Oct 2023 //
INDIAN PHARMA POST
Laurus Labs` Generic Metformin Hydrochloride Receives Approval in the U.S.
05 Oct 2023 //
FDA
Laurus Labs signs MOA with IIT Kanpur for novel gene therapy assets
19 Jun 2023 //
INDIANPHARMAPOST
Laurus Labs invests Rs 80 crore in cell & gene therapy firm ImmunoACT
31 May 2023 //
ECONOMIC TIMES
Laurus Labs gets 2 USFDA observations for Visakhapatnam facility
12 Feb 2023 //
MEDICALDIALOGUE
Laurus Labs slumps to 52-week low as Kotak Institutional Equities downgrades
02 Dec 2022 //
MONEYCONTROL
Laurus Labs takes stake in Ethan Energy India
25 Nov 2022 //
INDIANPHARMAPOST
Laurus Labs gets Form 483 with 1 observation from USFDA
01 Nov 2022 //
BUSINESS-STANDARD
Laurus Labs planning Rs. 2,000 Cr Capex
27 Oct 2022 //
INDIANPHARMAPOST
Laurus Labs Generic Abacavir Sulfate Receives Approval in the U.S.
25 Jul 2022 //
FDA
Laurus Labs Generic Pirfenidone Receives Approval in the U.S.
19 Jul 2022 //
FDA
Laurus Labs will try to make ‘rare’ drugs affordable in India: CEO
03 May 2022 //
ECONOMIC TIMES
Laurus Labs will try to make ‘rare’ drugs affordable in India: CEO
02 May 2022 //
ET HEALTH
Laurus` Generic Lopinavir & Ritonavir Receives Approval in the U.S.
21 Mar 2022 //
FDA
Laurus Labs up 8% in two days on purchase orders from global pharma company
11 Feb 2022 //
BUSINESS-STANDARD
Laurus Labs` Generic Canagliflozin Receives Approval in the U.S.
28 Jan 2022 //
FDA
Laurus Labs inks pact with MPP to produce molnupiravir
21 Jan 2022 //
ECONOMIC TIMES
Laurus Labs acquires stake in IIT-Bombay incubated CAR-T cell therapy company
19 Nov 2021 //
ECONOMICTIMES
Unitaid, Clinton Health Access Initiative, and Laurus Labs announce agreement
14 Sep 2021 //
PRESS RELEASE
Laurus Labs, Unitaid and CHAI ink agreement for development of HIV medication
14 Sep 2021 //
PHARMABIZ
